Dr. Marcelo Villar, researcher at the Institute of Translational Medicine Research (CONICET - Universidad Austral) and Medical Director of Immunalgia Therapeutics, was interviewed by Realpolitik radio about advances in pain research and the drug that could become the first drug, worldwide, to treat a disease that until now lacks a specific treatment.